Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1458099

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1458099

Global In Vitro Fertilization Market Size, Share, Growth Analysis, By Product Type(Fresh Donor, Fresh Non-Donor), By End-use(Fertility Clinics, Surgical Centers) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).

The market for assisted reproductive technology (ART) treatments that entail fertilizing an egg with sperm outside of the human body is known as the global in vitro fertilization market. IVF is now a commonly used technique to treat infertility and help couples become pregnant. It includes a number of processes like fertilization, extraction of eggs, ovarian stimulation, and embryo transfer. The main goal of the IVF industry is to assist couples who are having trouble conceiving and provide them with a means of achieving a healthy pregnancy. When natural pregnancy is either impossible or unlikely to succeed, in vitro fertilization (IVF) is utilized. The market offers solutions to individuals and couples who want to become parents but are struggling with infertility. The incidence of infertility around the world have been increasing as a result of various diseases, delayed pregnancies, altered lifestyles, and hormonal imbalances. Success rates in in vitro fertilization (IVF) have increased dramatically due to technological developments in laboratory techniques, cryopreservation technologies, genetic testing, and embryo selection. Couples looking for dependable and successful reproductive treatments are drawn to these developments. Couples undergoing IVF therapy frequently face a difficult psychological and physical journey. For certain individuals or couples, the intense treatment regimen, unknown success rates, and psychological strain may serve as obstacles to pursuing in vitro fertilization. In developing nations, where access to reproductive treatments and knowledge of available options are expanding, there is a growing demand for IVF procedures. This offers chances for the development of IVF facilities in these areas and market expansion. Possibilities include the rising demand from developing nations and technology advancements that can enhance patient outcomes and success rates. As new methods and strategies are developed, the IVF industry keeps changing, giving couples looking to start or grow a family options and hope.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Fertilization Market Segmental Analysis

The product, end-use, and geographic segments of the worldwide in vitro fertilization market are split up. The market is divided into four categories based on product: frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Hospitals, surgery centers, research institutes, and fertility clinics make up the various end-user segments of the market. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

Drivers of the Global In Vitro Fertilization Market

Significant improvements in the reproductive technologies utilized in IVF operations were made in 2021. Time-lapse imaging techniques, for example, have made it possible to continuously watch the growth of embryos, which has improved selection and increased success rates. More people and couples chose to undertake IVF treatments as a result of these developments.

Restraints in the Global In Vitro Fertilization Market

In 2021, the expense of IVF procedures continued to be a major barrier. Many individuals and couples find IVF unaffordable due to the high costs of medication, laboratory procedures, and several treatment cycles. This is especially true for those who lack sufficient financial resources or insurance coverage.

Market Trends of the Global In Vitro Fertilization Market

Growing Trend in Genetic Testing: Preimplantation genetic testing (PGT) and other genetic testing methods were becoming more and more popular in IVF treatments in 2022. By enabling the screening of embryos for genetic abnormalities prior to implantation, PGT lowers the risk of genetic problems in kids and increases the likelihood of successful pregnancies.

Growing Emphasis on Personalized Medicine: In the IVF industry, personalized medicine became more well-known in 2021. The strategy entails customizing IVF treatment plans according to the unique characteristics of each patient, including age, ovarian reserve, and unique reproductive issues. The goal of personalized medicine is to increase the effectiveness of IVF treatments and maximize treatment results.

Product Code: SQMIG35H2163

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global In Vitro Fertilization Market by Product Type

  • Market Overview
  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • and Frozen Non-Donor

Global In Vitro Fertilization Market by End-use

  • Market Overview
  • Fertility Clinics
  • Surgical Centers
  • Hospitals
  • Research Institutes

Global In Vitro Fertilization Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • CooperSurgical, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Irvine Scientific (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Micro Pte Ltd (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hamilton Thorne, Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nidacon International AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rocket Medical plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMD Serono (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OvaScience (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kitazato Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IVFtech Aps (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zeiss Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Igenomix (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Labotect GmbH (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Medical (Singapore)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!